Advertisement

The new agreement gives SciFluor access to technology that enables rapid synthesis of 18F-labeled molecules for PET imaging. The company said the technology lends itself to more informed and predictive drug development. SciFluor previously announced an exclusive, worldwide license from Harvard to various fluorination methods and to a portfolio of novel fluorinated compounds.

SOURCE

Advertisement
Advertisement